Back to Journals » Drug Design, Development and Therapy » Volume 13

Quizartinib (AC220): a promising option for acute myeloid leukemia

Total article views   HTML views PDF downloads Totals
9,093 Dovepress* 7,214+ 1,690 8,904
PubMed Central* 1,879 608 2,487
Totals 9,093 2,298 11,391
*Since 8 April 2019

View citations on PubMed Central and Google Scholar